Pressure Support Ventilation Versus Continuous Positive Air Way Pressure (CPAP) Using I Gelin Adult Patients,
1 other identifier
interventional
38
1 country
1
Brief Summary
Introduction of Supra glottic airway devices (SAD) has revolutionized the airway management. The first successful supraglottic airway device, the Laryngeal Mask Airway(LMA).The various other SADs include ProSeal LMA, Intubating LMA and i-gel to overcome the limitations of classic Laryngeal Mask Airway( c-LMA) The risk of aspiration with c-LMA is reported tobe around 9% , pleaseboth the c-LMA and PLMA have cuff related complications. High cuff pressure in laryngeal mask airways can cause damage to the mucosae on periglottic and supraglottic structures . Therefore, to overcome the limitations of Pro Seal Laryngeal Mask Airway (PLMA )a new and cheaper SAD called i-gel was developed. i-gel is a novel and innovative, latex free supraglottic device, made up of medical grade thermoplastic elastomer, which is soft, gel like, transparent The number of manipulations required are more in PLMA than i gel resulting in hemodynamic changes .The i-gel is comparable to PLMA insuring the airway during controlled ventilation. It is better than PLMA in terms of ease of insertion. Spontaneous breathing is the most popular mode of ventilation with the laryngeal mask airway (LMA), but it provides less effective gas exchange than does positive pressure ventilation (PPV) . The patients receiving sevoflurane anesthesia with unassisted ventilation have a reduced rib cage contribution to ventilation, decreased tidal volume, and respiratory rate . Pressure support ventilation (PSV) is a ventilator mode that is initiated by the patient and synchronized with the patient's respiratory effort. And may improve gaseous exchange in patients. In the intensive care unit, it is often considered the preferred mode for weaning mechanical ventilation .PSV provides more effective gas exchange than does unassisted ventilation with CPAP during anesthesia with the LMA while preserving hemodynamic homeostasis. The use of PSV versus CPAP with the Pro Seal laryngeal mask airway in anesthetized pediatric patients revealed that PSV improved gaseous exchange and reduced work of breathing during general anesthesia PSV via Pro- Seal laryngeal mask airway improves gaseous exchange and ventilation in pediatric patients under general anesthesia more than spontaneous ventilation .
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 31, 2019
CompletedFirst Submitted
Initial submission to the registry
August 20, 2021
CompletedFirst Posted
Study publicly available on registry
November 11, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 28, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
October 15, 2022
CompletedNovember 19, 2021
November 1, 2021
2.7 years
August 20, 2021
November 16, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Effective ventilation with PSV than does (CPAP) as regard Tidal volume
Breathing of all patients at the first 15 minutes with PSV pressure support ventilation:triggered by minute volume \<3 liter,with no frequency then the following 15 minutes ventilation with CPAP .ventilation will be measured by Monitoring: (basal\& every 3minutes)Tidal volume (inspiratory \& expiratory).on ventilator monitor in mil/ kilogram
30 minutes
Effective ventilation with PSV than does (CPAP) as regard End tidal co2. on ventilator
Breathing of all patients at the first 15 minutes with PSV pressure support ventilation:triggered by minute volume \<3 liter,with no frequency then the following 15 minutes ventilation with CPAP.ventilation will be measured by Monitoring: (basal\& every 3minutes) End tidal co2. on ventilator ml/eq
30 minutes
Effective ventilation with PSV than does CPAP as regard Mean air way pressure
Breathing of all patients at the first 15 minutes with PSV pressure support ventilation:triggered by minute volume \<3 liter,with no frequency then the following 15 minutes ventilation with CPAP.ventilation will be measured by Monitoring: (basal\& every 3minutes) Mean air way pressure.on ventilator mmhg
30 minutes
Effective ventilation with PSV than does (CPAP) as regard Leakage %
Breathing of all patients at the first 15 minutes with PSVpressure support ventilation:triggered by minute volume \<3 liter,with no frequency then the following 15 minutes ventilation with CPAP.ventilation will be measured by Monitoring: (basal\& every 3minutes) Leakage % on ventilator monitor
30 minutes
Effective ventilation with PSV than does CPAP as regard oxygen saturation.
Breathing of all patients at the first 15 minutes with PSV pressure support ventilation:triggered by minute volume \<3 liter,with no frequency then the following 15 minutes ventilation with CPAP.ventilation will be measured by Monitoring: (basal\& every 3minutes) oxygen saturation.on monitoring in %
30 minutes
Effective ventilation with PSV than does (CPAP) as regard respiratory rate
Breathing of all patients at the first 15 minutes with PSV pressure support ventilation:triggered by minute volume \<3 liter,with no frequency then the following 15 minutes ventilation with CPAP .ventilation will be measured by Monitoring: (basal\& every 3minute)respiratory rate on monitor breath/ minute
30 minutes
Study Arms (2)
the first 15 minutes with PSV
PLACEBO COMPARATORAll patients will breath at the first 15 minutes with PSV:triggered by minute volume \<3 Liter,with with no frequency . Monitoring: (basal\&every 3minutes) 1. Tidal volume (inspiratory \& expiratory). 2. End tidal co2. 3. Mean air way pressure. 4. Leakage %. 5. Respiratory rate . 6. Spo2. 7. Heart rate. 8. Blood pressure (mean arterial pressure
the following 15 minutes ventilation will be changed to CPAP mode
ACTIVE COMPARATORthen the following 15 minutes ventilation will be changed to CPAP mode at 10 cm H2o . Monitoring: (basal\&every 3minutes) 1. Tidal volume (inspiratory \& expiratory). 2. End tidal co2. 3. Mean air way pressure. 4. Leakage %. 5. Respiratory rate . 6. Spo2. 7. Heart rate. 8. Blood pressure (mean arterial pressure).
Interventions
PSV pressure support ventilation:triggered by minute volume \< 3 Liter ,with no frequency
continous positive air way pressure CPAP mode at 10 cm H2o .
supraglottic air way device
Eligibility Criteria
You may qualify if:
- Adult patients with (ASA) physical status I - II years scheduled for minor surgery at Urology and Nephrology centre (UNC) will be included in this study.
You may not qualify if:
- The Patients with a body mass index (BMI) \>40 or having obstructive air way disease will be excluded.•
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Marwa Ibrahim Mohamed abdo
Al Mansurah, Egypt
Related Publications (11)
Barker P, Langton JA, Murphy PJ, Rowbotham DJ. Regurgitation of gastric contents during general anaesthesia using the laryngeal mask airway. Br J Anaesth. 1992 Sep;69(3):314-5. doi: 10.1093/bja/69.3.314.
PMID: 1389850BACKGROUNDWong JG, Heaney M, Chambers NA, Erb TO, von Ungern-Sternberg BS. Impact of laryngeal mask airway cuff pressures on the incidence of sore throat in children. Paediatr Anaesth. 2009 May;19(5):464-9. doi: 10.1111/j.1460-9592.2009.02968.x. Epub 2009 Mar 5.
PMID: 19281479BACKGROUNDLevitan RM, Kinkle WC. Initial anatomic investigations of the I-gel airway: a novel supraglottic airway without inflatable cuff. Anaesthesia. 2005 Oct;60(10):1022-6. doi: 10.1111/j.1365-2044.2005.04258.x.
PMID: 16179048BACKGROUNDChauhan G, Nayar P, Seth A, Gupta K, Panwar M, Agrawal N. Comparison of clinical performance of the I-gel with LMA proseal. J Anaesthesiol Clin Pharmacol. 2013 Jan;29(1):56-60. doi: 10.4103/0970-9185.105798.
PMID: 23493414BACKGROUNDVerghese C, Brimacombe JR. Survey of laryngeal mask airway usage in 11,910 patients: safety and efficacy for conventional and nonconventional usage. Anesth Analg. 1996 Jan;82(1):129-33. doi: 10.1097/00000539-199601000-00023.
PMID: 8712387BACKGROUNDKeller C, Sparr HJ, Luger TJ, Brimacombe J. Patient outcomes with positive pressure versus spontaneous ventilation in non-paralysed adults with the laryngeal mask. Can J Anaesth. 1998 Jun;45(6):564-7. doi: 10.1007/BF03012709.
PMID: 9669012BACKGROUNDTokioka H, Nagano O, Ohta Y, Hirakawa M. Pressure support ventilation augments spontaneous breathing with improved thoracoabdominal synchrony in neonates with congenital heart disease. Anesth Analg. 1997 Oct;85(4):789-93. doi: 10.1097/00000539-199710000-00013.
PMID: 9322456BACKGROUNDFarias JA, Frutos F, Esteban A, Flores JC, Retta A, Baltodano A, Alia I, Hatzis T, Olazarri F, Petros A, Johnson M. What is the daily practice of mechanical ventilation in pediatric intensive care units? A multicenter study. Intensive Care Med. 2004 May;30(5):918-25. doi: 10.1007/s00134-004-2225-5. Epub 2004 Mar 17.
PMID: 15029473BACKGROUNDBrimacombe J, Keller C, Hormann C. Pressure support ventilation versus continuous positive airway pressure with the laryngeal mask airway: a randomized crossover study of anesthetized adult patients. Anesthesiology. 2000 Jun;92(6):1621-3. doi: 10.1097/00000542-200006000-00019.
PMID: 10839911BACKGROUNDvon Goedecke A, Brimacombe J, Hormann C, Jeske H-, Kleinsasser A, Keller C. Pressure support ventilation versus continuous positive airway pressure ventilation with the ProSeal laryngeal mask airway: a randomized crossover study of anesthetized pediatric patients. Anesth Analg. 2005 Feb;100(2):357-360. doi: 10.1213/01.ANE.0000143563.39519.FD.
PMID: 15673856BACKGROUNDLim B, Pawar D, Ng O. Pressure support ventilation vs spontaneous ventilation via ProSeal laryngeal mask airway in pediatric patients undergoing ambulatory surgery: a randomized controlled trial. Paediatr Anaesth. 2012 Apr;22(4):360-4. doi: 10.1111/j.1460-9592.2012.03819.x.
PMID: 22380745BACKGROUND
MeSH Terms
Conditions
Study Officials
- STUDY CHAIR
Golnar Se Hammouda, M.D
Professor of Anesthesia Intensive Care Faculty of Medicine - Mansoura University
- STUDY DIRECTOR
Hanaa Ma El-Bendary, M.D
Assistant Professor of Anesthesia Intensive Care Faculty of Medicine - Mansoura University
- PRINCIPAL INVESTIGATOR
Marwa Ib Abdo, M.D
Lecturer of Anesthesia Intensive Care Faculty of Medicine - Mansoura University
- PRINCIPAL INVESTIGATOR
Bahaa Mo Ezz, MBBCh
Resident of Anesthesia Intensive Care Mansoura University Hospitals
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer of Anesthesia and Surgical Intensive Care-Faculty of Medicine - Mansoura University
Study Record Dates
First Submitted
August 20, 2021
First Posted
November 11, 2021
Study Start
March 31, 2019
Primary Completion
December 28, 2021
Study Completion
October 15, 2022
Last Updated
November 19, 2021
Record last verified: 2021-11
Data Sharing
- IPD Sharing
- Will not share